Genentech

Genentech lines up a new autoimmune R&D alliance on a 'potentially transformative' tech
Genentech lines up a new autoimmune R&D alliance on a 'potentially transformative' tech
Endpoints
Parvus Therapeutics
Genentech
drug discovery
autoimmune disease
Flag link:
Experimental Drug For Huntington's Disease Jams Malfunctioning Gene
Experimental Drug For Huntington's Disease Jams Malfunctioning Gene
NPR
Huntington's disease
RG6042
clinical trials
Roche
Genentech
Flag link:
Genentech backs U.K. accelerator to help pre-A round startups
Genentech backs U.K. accelerator to help pre-A round startups
Fierce Biotech
Genentech
startups
Start Codon
Flag link:
Study Shows that Using AI in Eye Screenings Could Help Improve Vision Outcomes
Study Shows that Using AI in Eye Screenings Could Help Improve Vision Outcomes
Medical Devices and Diagnostics Industry
eye health
artificial intelligence
Roche
Genentech
diabetic macular edema
Flag link:
Roche’s Tecentriq gains new US lung cancer indication
Roche’s Tecentriq gains new US lung cancer indication
Pharmaforum
Roche
Genentech
Tecentriq
FDA
extensive-stage small cell lung cancer
Flag link:
Pfizer gets FDA approval for oncology biosimilar Trazimera
Pfizer gets FDA approval for oncology biosimilar Trazimera
Pharmaceutical Business Review
Pfizer
FDA
Trazimera
Genentech
biosimilars
Herceptin
Flag link:
Roche's Tecentriq gains expanded approval in US for PD-L1-positive, triple-negative breast cancer
Roche's Tecentriq gains expanded approval in US for PD-L1-positive, triple-negative breast cancer
First Word Pharma
Roche
Genentech
FDA
Tecentriq
triple negative breast cancer
Flag link:
Roche Study Shows AI Can Detect Severity of Diabetic Macular Edema
Roche Study Shows AI Can Detect Severity of Diabetic Macular Edema
BioSpace
artificial intelligence
Roche
Genentech
telemedicine
diabetic macular edema
devices
Flag link:
Genentech Submits sNDA For Venclexta and Gazyva Combo for Chronic Lymphocytic Leukemia
Genentech Submits sNDA For Venclexta and Gazyva Combo for Chronic Lymphocytic Leukemia
CP Wire
Genentech
Roche
AbbVie
chronic lymphocytic leukemia
Gazyva
Venclexta
Flag link:
Genentech Submits sNDA For Venclexta and Gazyva Combo for Chronic Lymphocytic Leukemia
Genentech
Roche
AbbVie
chronic lymphocytic leukemia
Gazyva
Venclexta
Flag link:
Executive Provides Mentorship and Promotes Diversity at Genentech
Executive Provides Mentorship and Promotes Diversity at Genentech
BioSpace
diversity
Genentech
Roche
Flag link:
Layoffs Hit California Biopharma Companies
Layoffs Hit California Biopharma Companies
BioSpace
layoffs
Roche
Genentech
Pfizer
Aduro BioTech
Theravance
Merck
Flag link:
Judge skeptical of JHL's defense in Genentech case
Judge skeptical of JHL's defense in Genentech case
BioCentury
Genentech
JHL Biotech
trade secrets
Flag link:
Japan's Love for Genentech’s Xofluza Flu Treatment May Be Waning
Japan's Love for Genentech’s Xofluza Flu Treatment May Be Waning
BioSpace
Xofluza
Japan
Genentech
Flag link:
Genentech Plans Legal Battle to Protect Esbriet from Generic Competition
Genentech Plans Legal Battle to Protect Esbriet from Generic Competition
BioSpace
Genentech
Roche
idiopathic pulmonary fibrosis
Esbriet
generics
Flag link:
The bispecific boom: Genentech pays $120M to tie the knot with Xencor on an IL-15 alliance
The bispecific boom: Genentech pays $120M to tie the knot with Xencor on an IL-15 alliance
Endpoints
Genentech
Xencor
IL-15
XmAb24306
cancer
bispecific antibodies
Flag link:
Report: five companies would take brunt of Trump Part B proposal
Report: five companies would take brunt of Trump Part B proposal
BioCentury
Donald Trump
Medicare Part B
Amgen
Regeneron
Bristol-Myers Squibb
Genentech
Roche
Flag link:
Last week in biopharma - earnings reports, drug pricing, a new GENE CEO and more
Last week in biopharma - earnings reports, drug pricing, a new GENE CEO and more
CP Wire
earnings
drug pricing
Genentech
Eli Lilly
Medtronic
Roche
M&A
Takeda
GSK
FDA
Flag link:
Last week in biopharma-earnings reports, drug pricing, a new GENE CEO and more
earnings
drug pricing
Genentech
Eli Lilly
Medtronic
Roche
M&A
Takeda
GSK
FDA
Flag link:
Alexander Hardy tapped to head back to South San Francisco as the next CEO at Genentech
Alexander Hardy tapped to head back to South San Francisco as the next CEO at Genentech
Endpoints
Genentech
Roche
Alexander Hardy
Pharma CEOs
Flag link:

Pages